The epidemiology of schizophrenia: replacing dogma with knowledge
about
The dappled nature of causes of psychiatric illness: replacing the organic-functional/hardware-software dichotomy with empirically based pluralismDeletion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviorsHippocampal deep brain stimulation reverses physiological and behavioural deficits in a rodent model of schizophrenia.Development of antipsychotic medications with novel mechanisms of action based on computational modeling of hippocampal neuropathology.Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells.Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia.Genome-wide methylation profiling of schizophrenia.Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia.AKT/GSK3 signaling pathway and schizophreniaMolecular Signatures of Psychosocial Stress and Cognition Are Modulated by Chronic Lithium Treatment.Aberrant dopamine D2-like receptor function in a rodent model of schizophrenia.Lack of gender influence on cortical and subcortical gray matter development in childhood-onset schizophrenia.A loss of hippocampal perineuronal nets produces deficits in dopamine system function: relevance to the positive symptoms of schizophrenia.Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposureNew approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways.Continuous assessment of schizophrenia using heart rate and accelerometer data.Cell-based therapies for the treatment of schizophrenia.Towards therapeutic applications of arthropod venom k(+)-channel blockers in CNS neurologic diseases involving memory acquisition and storage.Characterization of Behavioral, Signaling and Cytokine Alterations in a Rat Neurodevelopmental Model for Schizophrenia, and Their Reversal by the 5-HT6 Receptor Antagonist SB-399885.
P2860
Q22251102-A909CBE3-8A99-4AC3-8D60-C639E838E869Q28512821-C2568BF1-D6B9-43B3-BF07-16659D75A7FFQ30540732-D94355E0-542A-4F36-B911-27C255AE0AF6Q31113942-D5823DCB-AED7-43D1-BFB6-FAE502C792F1Q33693380-21E94C3B-A2D1-4F78-8DDE-0514AE967D8CQ34845881-990ADFF9-BD23-4B2C-8C6E-BE33D5651FBBQ35175354-C162D018-4011-4EEC-A452-CFA669CA45A7Q35549644-E958A600-D422-4D6E-8BCB-A06892675540Q35760215-863C26B0-CAF0-49B4-9FBA-163F9418672CQ35832061-2C02F3B2-B306-4CC8-8F8E-D07F7C282162Q35880985-00F3F76A-CA5B-405A-BE0A-DC7C976A2679Q36335503-A6ECF013-5918-4193-B000-E23567ED4F1CQ36471489-F476D83C-590F-4DDD-B2AA-1186A72A8F2EQ36593850-73B00775-A23B-4453-BC31-814F7F5EF0D5Q37282162-DF42109C-EAEE-4993-B1F7-7D7E1A8D04AAQ38233857-14F5FCAA-5A7C-4DF7-B286-4FC1DCE71A9EQ38707486-CEBDC1E7-F2B5-4306-BE61-95989D085E1CQ38932809-CA0DA3DF-BC9E-4E0A-A99E-2655E169F6F7Q42175839-6A3DC037-F55B-46DD-906A-C8BD63DE25BAQ50052167-27B334BD-5768-4A94-9F8F-417EE12B7F76
P2860
The epidemiology of schizophrenia: replacing dogma with knowledge
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The epidemiology of schizophrenia: replacing dogma with knowledge
@ast
The epidemiology of schizophrenia: replacing dogma with knowledge
@en
type
label
The epidemiology of schizophrenia: replacing dogma with knowledge
@ast
The epidemiology of schizophrenia: replacing dogma with knowledge
@en
prefLabel
The epidemiology of schizophrenia: replacing dogma with knowledge
@ast
The epidemiology of schizophrenia: replacing dogma with knowledge
@en
P2860
P1476
The epidemiology of schizophrenia: replacing dogma with knowledge
@en
P2093
Robin M Murray
Simona A Stilo
P2860
P304
P577
2010-01-01T00:00:00Z